Side populations of glioblastoma cells are less sensitive to HSV-TK/GCV suicide gene therapy system than the non-side population

scientific article

Side populations of glioblastoma cells are less sensitive to HSV-TK/GCV suicide gene therapy system than the non-side population is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S11626-010-9274-6
P698PubMed publication ID20135358

P2093author name stringWeiguo Liu
Weiwei Hu
P2860cites workThe extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitroQ24564192
The 2007 WHO classification of tumours of the central nervous systemQ24685772
The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotypeQ29615563
ABCG2-associated resistance to Hoechst 33342 and topotecan in a murine cell model with constitutive expression of side population characteristicsQ33508609
Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication.Q34005910
Long-term glioblastoma multiforme survivors: a population-based study.Q34750725
Cancer stem cells in nervous system tumorsQ35892122
Stem cells in the etiology and treatment of cancerQ36353139
Cancer stem cells and survival pathwaysQ37141755
Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenograftsQ39924899
Enhanced combined tumor-specific oncolysis and suicide gene therapy for prostate cancer using M6 promoterQ39942987
Gefitinib ("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance.Q40453744
Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein.Q40904151
PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cellsQ42148487
In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain TumorsQ42818740
Immune response induced by retrovirus-mediated HSV-tk/GCV pharmacogene therapy in patients with glioblastoma multiforme.Q43636591
Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma.Q43761368
Combination gene therapy for glioblastoma involving herpes simplex virus vector-mediated codelivery of mutant IkappaBalpha and HSV thymidine kinaseQ45251720
Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl)guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or typQ45775557
Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategyQ70147645
Acyclic guanosine analogs inhibit DNA polymerases alpha, delta, and epsilon with very different potencies and have unique mechanisms of actionQ72585448
P433issue6
P921main subjectsuicideQ10737
glioblastomaQ282142
gene therapyQ213901
P304page(s)497-501
P577publication date2010-02-05
P1433published inIn Vitro Cellular & Developmental Biology - AnimalQ1524094
P1476titleSide populations of glioblastoma cells are less sensitive to HSV-TK/GCV suicide gene therapy system than the non-side population
P478volume46

Reverse relations

cites work (P2860)
Q38841046Cancer suicide gene therapy: a patent review.
Q98289803Complete regression of metastatic de-differentiated liposarcoma with engineered mesenchymal stromal cells with dTRAIL and HSV-TK
Q39064497Enzyme/Prodrug Systems for Cancer Gene Therapy.
Q37981990Flow cytometry in cancer stem cell analysis and separation
Q36534930Frontiers in Suicide Gene Therapy of Cancer
Q38262019Gene-directed enzyme prodrug therapy
Q38003156Human ABCG2: structure, function, and its role in multidrug resistance.
Q36527593The art of gene therapy for glioma: a review of the challenging road to the bedside

Search more.